Thyroid Cancer and Structural Thyroid Disease in Patients with Acromegaly: A Systematic Review and Meta-Analysis

Abstract Purpose Acromegaly causes chronic growth hormone and insulin-like growth factor-1 excess, which may promote thyroid proliferation. Whether acromegaly increases thyroid cancer and structural thyroid disease odds remains uncertain. So we aim to determine whether patients with acromegaly have higher odds of thyroid cancer and structural thyroid abnormalities than individuals without acromegaly. Methods PubMed, Embase, and Cochrane Library were searched from inception to March 2026. Observational comparative studies of patients with acromegaly and non-acromegaly comparators reporting thyroid outcomes were eligible. Case reports, case series, reviews, abstracts, overlapping populations and studies without comparative thyroid cancer data were excluded. Two reviewers independently screened records; 13 of 2,623 were included. Three reviewers independently extracted study characteristics, participant data, acromegaly criteria, thyroid cancer subtypes, nodular disease, volume, and biochemical outcomes. Risk of bias was assessed using ROBINS-E or JBI, and certainty was evaluated using GRADE. Results Thirteen studies included 719,090 participants; 2,674 had acromegaly. Acromegaly was associated with higher odds of overall thyroid cancer (OR 4.00, 95% CI 2.21–7.24), papillary carcinoma (OR 2.81, 95% CI 1.60–4.91) and thyroid nodular disease (OR 2.60, 95% CI 1.80–3.76). Thyroid volume was greater in acromegaly (MD 12.57 mL, 95% CI 5.27–19.86). Follicular thyroid carcinoma, free thyroxine and thyroid-stimulating hormone did not differ significantly. Conclusion Acromegaly was associated with thyroid cancer and structural thyroid disease, but not with significant differences in routine thyroid function markers.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11544054/v1
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Thyroid Cancer and Structural Thyroid Disease in Patients with Acromegaly: A Systematic Review and Meta-Analysis

Soemiwati Weidris Holland, Miray Kurtca, Osvaldo Sampaio Netto, Marina Carvalho Robichez Penna et al.
Research Square
Thyroid Cancer Diagnosis and Treatment
preprint

Thyroid Cancer and Structural Thyroid Disease in Patients with Acromegaly: A Systematic Review and Meta-Analysis

Soemiwati Weidris Holland, Miray Kurtca, Osvaldo Sampaio Netto, Marina Carvalho Robichez Penna, Ana Luiza Potiguara de Sousa, Andressa Frankowski Dagostin, Pedro Diniz Rocha Guimarães, Tatiana Fonseca Silva, Paulo Henrique Potiguara de Sousa, Cejana Mello Campos, Rosily Philip, Neuza Lopes Araujo Faria
preprint en

Abstract

Abstract Purpose Acromegaly causes chronic growth hormone and insulin-like growth factor-1 excess, which may promote thyroid proliferation. Whether acromegaly increases thyroid cancer and structural thyroid disease odds remains uncertain. So we aim to determine whether patients with acromegaly have higher odds of thyroid cancer and structural thyroid abnormalities than individuals without acromegaly. Methods PubMed, Embase, and Cochrane Library were searched from inception to March 2026. Observational comparative studies of patients with acromegaly and non-acromegaly comparators reporting thyroid outcomes were eligible. Case reports, case series, reviews, abstracts, overlapping populations and studies without comparative thyroid cancer data were excluded. Two reviewers independently screened records; 13 of 2,623 were included. Three reviewers independently extracted study characteristics, participant data, acromegaly criteria, thyroid cancer subtypes, nodular disease, volume, and biochemical outcomes. Risk of bias was assessed using ROBINS-E or JBI, and certainty was evaluated using GRADE. Results Thirteen studies included 719,090 participants; 2,674 had acromegaly. Acromegaly was associated with higher odds of overall thyroid cancer (OR 4.00, 95% CI 2.21–7.24), papillary carcinoma (OR 2.81, 95% CI 1.60–4.91) and thyroid nodular disease (OR 2.60, 95% CI 1.80–3.76). Thyroid volume was greater in acromegaly (MD 12.57 mL, 95% CI 5.27–19.86). Follicular thyroid carcinoma, free thyroxine and thyroid-stimulating hormone did not differ significantly. Conclusion Acromegaly was associated with thyroid cancer and structural thyroid disease, but not with significant differences in routine thyroid function markers.

Research Square
Universidade Católica de Brasília (BR), Richmond University Medical Center (US), Hackensack Meridian School of Medicine (US)
Good health and well-being
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon